Journal of Alzheimer's Research and Therapy

Aims and Scope

Journal of Alzheimer's Research and Therapy (JALR) is committed to publishing manuscripts that break new ground in the field of AD treatment, prevention, and management, and that advance the understanding of basic biology, epidemiology, and biostatistics related to the disease.

JALR publishes substantial original research articles, review articles, case reports, and clinical studies in all aspects of Alzheimer's disease. JALR encourages submission of papers that make seminal discoveries that advance the field of Alzheimer's research.

The aims of JALR are:

To provide a forum for exchange of ideas among scientists, clinicians, and other healthcare providers in the field of Alzheimer's Disease.

To promote research in all aspects of Alzheimer's disease, including its diagnosis, prevention, treatment, and management.

To provide a comprehensive overview of current research, practice, and management of patients with Alzheimer's Disease.

To bridge the gap between basic science and clinical research in the field of Alzheimer’s disease.

To promote education and training of professionals in the field of Alzheimer's Disease.

To facilitate the transfer of knowledge among scientists, clinicians, and healthcare providers in the field of Alzheimer's Disease.

The field of JALR is vast as

• Pathology and Pathophysiology 
• Diagnosis and Prognosis 
• Clinical Aspects of Alzheimer's Disease 
• Neuropsychiatry and Neurodegeneration 
• Neuroimaging and Neuropsychology 
• Neurochemistry and Neuropharmacology 
• Molecular Genetics, Genomics, and Proteomics 
• Therapeutic Strategies 
• Epidemiology and Biostatistics 
• Clinical Trials 
• Social and Psychological Aspects 
• Primary progressive aphasia (PPA)
• Senile dementia
• Palliative care
• Memory
• Lifestyle
• Alzheimer's disease
• Clinical depression
• Lewy body dementia
• Epidemiology
• Apraxia
• Etiology
• Atrophy
• Diet
• Neurology
• Genetics
• Vascular dementia
• Biochemistry
• Pathophysiology
• Gene Therapy
• Traumatic brain injury
• Medication
• Neurological disorders
• Agnosia
• Frontotemporal dementia
• Clinical trials
• Medications
• Antioxidant
• Memory loss
• Anatomical
• Parkinsonism
• Anomia
• Amyloid
• Mild cognitive impairment
• Neurodegenerative disease
• Dementia with Lewy bodies
• Forgetfulness
• Disorientation
• Amyloid plaques
• Environmental Factors
• Movement Disorder
• Neuropathology
• Neurofibrillary tangles
• Alzheimer's dementia
• Cognitive dysfunction
• Amnestic
• Neurodegeneration
• Estrogen replacement therapy
• Early Dementia
• Synaptic plasticity
• Cholinesterase inhibitor
• Brain disorder
• Translational
• Mixed dementia
• Advanced Dementia
• Moderate Dementia
• Alzheimer's care
• Neurodegenerative Disorder
• Managing dementia